News Room Less than 1 min.Read Festi hf.: Major shareholder announcement from Lífeyrissjóður verzlunarmanna Festi hf.: Major shareholder announcement from Lífeyrissjóður verzlunarmanna By Investing Today November 20, 2025 FacebookTwitterPinterestWhatsApp Please see attached major shareholder announcement. Attachment Festi hf. – 20. nov Flöggun LIVE Powered by SlickText.com Hot this week News Room Arcadis presents its 2027-2029 Business Strategy during the Capital Markets Day on the 29th of September 2026 September 9, 2026 0 PRESS RELEASE Register now! Arcadis presents... News Room Dassault Aviation: Reception of the First Two Falcon Albatros Aircraft by the DGA September 9, 2026 0 Reception of the First Two Falcon Albatros Aircraft by... News Room Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers September 9, 2026 0 Basel, Switzerland and Chassieu, France, , Sept. 09,... News Room ZetaDisplay to Deliver First Retail Media Network for SPAR September 9, 2026 0 ZetaDisplay to Deliver First Retail Media Network... News Room Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial September 9, 2026 0 - Treatment with oral infigratinib for 52 weeks in... Topics News Room Arcadis presents its 2027-2029 Business Strategy during the Capital Markets Day on the 29th of September 2026 0 PRESS RELEASE Register now! Arcadis presents... News Room Dassault Aviation: Reception of the First Two Falcon Albatros Aircraft by the DGA 0 Reception of the First Two Falcon Albatros Aircraft by... News Room Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers 0 Basel, Switzerland and Chassieu, France, , Sept. 09,... News Room ZetaDisplay to Deliver First Retail Media Network for SPAR 0 ZetaDisplay to Deliver First Retail Media Network... News Room Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial 0 - Treatment with oral infigratinib for 52 weeks in... News Room Premium Catering (Holdings) Limited Receives NASDAQ Notice Related to Late Filing of Its Interim Report 0 New York, NY, Sept. 09, 2026 (GLOBE NEWSWIRE)... News Room Ensurge Micropower Relocates to New San Jose Facility to Advance Solid-State Microbattery Development 0 New building will accelerate pilot-line capabilities and customer engagement... News Room Riverside Resources Intersects Near-Surface Gold and Base Metal Mineralization at Union Norte and Advances Multiple Targets for Phase 2B Drilling 0 VANCOUVER, British Columbia, Sept. 09, 2026 (GLOBE NEWSWIRE)... Related Articles Arcadis presents its 2027-2029 Business Strategy during the Capital Markets Day on the 29th of September 2026 News Room September 9, 2026 Dassault Aviation: Reception of the First Two Falcon Albatros Aircraft by the DGA News Room September 9, 2026 Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers News Room September 9, 2026 ZetaDisplay to Deliver First Retail Media Network for SPAR News Room September 9, 2026 Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial News Room September 9, 2026 Popular Categories News RoomFeatured CompaniesVideos Previous articleOlivier Domergue joins the Management Board of Solutions30Next articleCNH announces pricing of its offering of €500,000,000 3.625% notes due January 2033